Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Watch the video of the SHAAP/SARN 'Alcohol Occasionals' webinar, held over Zoom on 24 May 2023: "Alcohol marketing to LGBTQ+ people: Evolving strategies to target identity", by Dr David Whiteley .
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
A team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and hypersensitivity.
Chronic alcohol consumption may make people more sensitive to pain through two different molecular mechanisms -- one driven by...
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
National Drug Observatories (NDOs) from Latin American and Caribbean (LAC) countries are gathering in Lisbon from 22–26 May for a week of activities under the COPOLAD III programme.
The overarching theme of the initiative will be...
The May 2023 Preventive Medicine Grand Rounds (PMGR) features Recovery Kentucky, a social model program that provides housing and recovery services for rural Kentuckians dealing with substance use disorder. The program is led by the...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
